Nasus Pharma Ltd SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE6-KNasus Pharma LtdNSRXOct 8

   Nasus Pharma Ltd holds shareholder meeting

   • Meeting held on October 8, 2026
   • All agenda items approved except Proposal No. 4
   • Proxy statement and notice included as exhibits
2. ROUTINE3Nasus Pharma LtdNSRXSep 23

   Oren Elmaliah, new insider at NSRX

   Oren Elmaliah, reporting

3. ROUTINE4Nasus Pharma LtdNSRXSep 21

   Eyal Rubin, insider filing for NSRX

   Eyal Rubin, reporting

4. ROUTINE424B5Nasus Pharma LtdNSRXSep 18

   Securities offering

5. ROUTINE6-KNasus Pharma LtdNSRXSep 18

   Foreign issuer report

6. ROUTINE6-KNasus Pharma LtdNSRXSep 14

   Foreign issuer report

7. ROUTINEEFFECTNasus Pharma LtdNSRXSep 14

   Registration declared effective

8. ROUTINE6-KNasus Pharma LtdNSRXSep 4

   Foreign issuer report

9. ROUTINEF-3Nasus Pharma LtdNSRXSep 2

   Securities offering

10. ROUTINEEFFECTNasus Pharma LtdNSRXAug 21

    Registration declared effective

11. ROUTINE6-KNasus Pharma LtdNSRXAug 19

    Foreign issuer report

12. ROUTINE6-KNasus Pharma LtdNSRXAug 17

    Foreign issuer report

13. ROUTINESCHEDULE 13G/ANasus Pharma LtdNSRXAug 14

    Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P. (amended)

    BALYASNY ASSET MANAGEMENT L.P., filed by

14. ROUTINE3Nasus Pharma LtdNSRXJul 31

    Brendan P. O'Grady, new insider at NSRX

    Brendan P. O'Grady, reporting

15. ROUTINE4Nasus Pharma LtdNSRXJul 29

    Dan Benjamin Teleman, insider filing for NSRX

    Dan Benjamin Teleman, reporting

16. ROUTINE6-KNasus Pharma LtdNSRXJul 28

    Foreign issuer report

17. ROUTINE4Nasus Pharma LtdNSRXJun 22

    Dan Benjamin Teleman, insider filing for NSRX

    Dan Benjamin Teleman, reporting

18. ROUTINE6-KNasus Pharma LtdNSRXJun 9

    Foreign issuer report

19. ROUTINES-8Nasus Pharma LtdNSRXMay 26

    Employee stock plan registration

20. ROUTINESCHEDULE 13GNasus Pharma LtdNSRXMay 15

    Ownership stake disclosure by BALYASNY ASSET MANAGEMENT L.P.

    BALYASNY ASSET MANAGEMENT L.P., filed by

21. ROUTINE4Nasus Pharma LtdNSRXApr 22

    Dan Benjamin Teleman, insider filing for NSRX

    Dan Benjamin Teleman, reporting

22. ROUTINESCHEDULE 13GNasus Pharma LtdNSRXApr 7

    Ownership stake disclosure by Funicular Funds, LP

    Funicular Funds, LP, filed by

23. ROUTINE4Nasus Pharma LtdNSRXApr 1

    Dan Benjamin Teleman, insider filing for NSRX

    Dan Benjamin Teleman, reporting

24. ROUTINEEFFECTNasus Pharma LtdNSRXApr 1

    Registration declared effective

25. ROUTINE3Nasus Pharma LtdNSRXMar 27

    8 insider filings

    Eyal Rubin, new insider at NSRX

    Show all 8

    • 3New insider at NSRXMar 27
    • 3New insider at NSRXMar 27
    • 3New insider at NSRXMar 27
    • 3New insider at NSRXMar 27
    • 3New insider at NSRXMar 27
    • 3New insider at NSRXMar 27
    • 3New insider at NSRXMar 27
    • 3New insider at NSRXMar 27

    Eyal Rubin, reporting

26. ROUTINEPOS AMNasus Pharma LtdNSRXMar 27

    POS AM filing

27. ROUTINE6-KNasus Pharma LtdNSRXMar 25

    Foreign issuer report

28. NOTABLE20-FNasus Pharma LtdNSRXMar 25

    Annual report

29. ROUTINE6-KNasus Pharma LtdNSRXMar 16

    Foreign issuer report

30. ROUTINEEFFECTNasus Pharma LtdNSRXMar 16

    Registration declared effective

31. ROUTINE6-KNasus Pharma LtdNSRXMar 6

    Foreign issuer report

32. ROUTINE6-KNasus Pharma LtdNSRXMar 4

    Foreign issuer report

33. NOTABLEF-1Nasus Pharma LtdNSRXMar 2

    Securities offering

34. ROUTINEDNasus Pharma LtdNSRXFeb 25

    Private placement notice

35. ROUTINE6-KNasus Pharma LtdNSRXFeb 13

    Foreign issuer report

36. ROUTINE6-KNasus Pharma LtdNSRXJan 29

    Foreign issuer report

37. ROUTINE6-KNasus Pharma LtdNSRXJan 20

    Foreign issuer report

38. ROUTINE6-KNasus Pharma LtdNSRXDec 29, 2025

    Foreign issuer report

39. ROUTINE6-KNasus Pharma LtdNSRXDec 22, 2025

    Foreign issuer report

40. ROUTINE6-KNasus Pharma LtdNSRXNov 20, 2025

    Nasus Pharma Ltd filed 6-K

    • Form Type: 6-K
    • Filing Date: 2025-11-20
41. ROUTINESCHEDULE 13GNasus Pharma LtdNSRXNov 13, 2025

    Ownership stake disclosure by Ronnie Hershman

    Ronnie Hershman, filed by

42. ROUTINESCHEDULE 13GNasus Pharma LtdNSRXNov 12, 2025

    Ownership stake disclosure by Dalia Megiddo

    Dalia Megiddo, filed by

43. ROUTINESCHEDULE 13GNasus Pharma LtdNSRXNov 10, 2025

    Ownership stake disclosure by Udi Gilboa

    Udi Gilboa, filed by

Older filings on EDGAR